oncgnostics develops – based on proprietary epigenetic biomarkers - highly reliable molecular in vitro diagnostic (IVD) tests for screening, follow-up care and therapeutic decisions in cancer diagnostics.
| Website | https://www.oncgnostics.com/ |
| Revenue | $5 million |
| Employees | 21 (2 on RocketReach) |
| Founded | 2012 |
| Phone | +49 4936 41933544 |
| Technologies |
JavaScript
,
HTML
,
PHP
+24 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Manufacturing General, Manufacturing, Science and Engineering, Other Devices and Supplies, Health Diagnostics, Health Care, Medical, Robotics, Hardware, Software |
| Competitors | Natera, Exact Sciences, Guardant Health, GRAIL, Myriad Genetics, Foundation Medicine, Caris Life Sciences, Freenome, Genomic Health, Biocept, Inc. +35 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 325413 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular oncgnostics GmbH employee's phone or email?
oncgnostics GmbH Questions
The oncgnostics GmbH annual revenue was $5 million in 2026.
Alfred Hansel is the Geschäftsführer of oncgnostics GmbH.
2 people are employed at oncgnostics GmbH.
The NAICS codes for oncgnostics GmbH are [325, 3254, 325413, 32541, 32].
The SIC codes for oncgnostics GmbH are [283, 28].
Top oncgnostics GmbH Employees
-
Alfred Hansel
Geschäftsführer at oncgnostics GmbH
Halle Neustadt, Saxony-Anhalt, Germany
Related Companies
